Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
暂无分享,去创建一个
N. de Las Heras | P. Giraldo | J. Steegmann | V. García-Gutiérrez | A. Álvarez-Larrán | J. Guinea | C. Boqué | G. Bautista | F. Ortega | S. Bobillo | G. Debén | A. Martı́nez-Trillos | B. Maestro | B. Cuevas | María Luisa Martin Mateos | E. Romero | A. Sebrango | J. Tallón | S. Valencia | A. Portero | José Luis López Lorenzo | Ana Iglesias Pérez | Andrés Romo Collado | Angeles Fernández | C. Ruiz | I. Mata | M. C. G. García Garay | M. R. Ramirez Sánchez | V. García‐Gutiérrez | M. R. Ramirez Sanchez | A. Fernández | Jose Luis Lopez Lorenzo | Maria Luisa Martin Mateos | Maria del Carmen García Garay | N. de las Heras